Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 613 pembrolizumab 563 Magnetic Resonance Spectroscopy 536 Carboplatin 425 Cisplatin 375 Cyclophosphamide 373 Biopsy 357 Paclitaxel 306 Gemcitabine 303 Nivolumab 300 Radiotherapy 260 Bevacizumab 234 Dexamethasone 209 fludarabine 205 Docetaxel 187 durvalumab 182 atezolizumab 173 Oxaliplatin 172 venetoclax 168 Fluorouracil 166 Rituximab 165 Pemetrexed 163 Capecitabine 158 Doxorubicin 157 Radiation 155 Radiosurgery 148 Etoposide 137 Leucovorin 133 Ipilimumab 133 Lenalidomide 131

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HM781-36B × 90 days × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡